Assembling evidence grade
Loading
Independent evidence before payment.
Small-molecule NNMT inhibitor
5-Amino-1MQ carries an Evidence Grade of D (Low confidence). The strongest published evidence catalogued is animal.
Grade D rule: Animal evidence only.
The grade reflects the strength of the published evidence, not safety or efficacy. “Confidence” means how settled that grade is given the record — not how likely the compound is to work.
Human-use stop
This compound is investigational, warned or not approved for human use. A seller calling it “research only,” showing testimonials, registering a company or publishing a COA does not create an approved consumer medicine. Seller links below are market-surveillance records, not recommendations.
5-Amino-1MQ is a small-molecule NNMT inhibitor studied preclinically for metabolic endpoints. It is not a peptide but is commonly grouped with this market.
Animal and in-vitro results are shown separately and must never be read as established human outcomes.
In plain terms: the research here is 1 animal study and 1 lab-bench study, with no human trials at all. Results in animals frequently do not repeat in people.
Strongest: randomised or pooled human trials.
none catalogued
Observational, open-label or small human studies.
none catalogued
Preclinical animal models — not a human outcome.
Animal metabolic model of NNMT inhibition.
Cell / tissue studies — not a human outcome.
none catalogued
Proposed mechanism — hypothesis, not evidence of effect.
Mechanistic enzyme-inhibition study.
Evidence is preclinical only. No human trials establish efficacy or safety.
Not an approved medicine in major markets. Sold only as a “research chemical”, with no established safe consumer use, dose or supply standard.
PepCred flags any vendor selling this compound to the public as a consumer-protection concern. Status reflects regulator records; see the regulatory detail below.
No FDA-approved (US) drug labelling found for this compound. A search of openFDA returned no approved product containing it as an active ingredient.
This reflects US FDA approval only — other regulators (e.g. MHRA, EMA) may differ; see the note below. Absence of an approved label is not, by itself, a safety finding, and a “research use only” label does not establish safety, legality or correct identity.
PepCred note: Not approved; no human authorisation.
These unranked records show where the name was detected. For an investigational, warned or unapproved compound, no seller, company registration, review score or COA creates an approved human-use route.
None of these is verified for human use.